Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Urinary Biomarkers in Traumatic Brain Injury: A Systematic Review

  1. 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  2. 2Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Abstract

An accurate diagnosis and longitudinal monitoring of traumatic brain injury (TBI) require non-invasive, objective metrics. This systematic review evaluates the clinical utility of urinary biomarkers across the TBI spectrum. Following the PRISMA 2020 guidelines, we searched PubMed and Web of Science and identified 25 empirical human studies after applying the inclusion and exclusion criteria. The included studies fell into four categories as follows: central nervous system structural and glial proteins, metabolomic and volatile signatures, peptidomic and systemic indicators, and emerging targets. Urinary S100B was associated with injury severity and, in one severe-TBI cohort, with one-month mortality at an area under the curve of 0.778, yet its discriminative value in mild TBI was limited by delayed renal excretion and pre-analytical confounders. Metabolomic and peptidomic panels showed promising classification accuracy in small cohorts, and early urinary liver-type fatty acid-binding protein and a depressed urine-to-serum osmolality ratio signaled secondary renal and neuroendocrine complications. Evidence for microRNAs, glycans, and the p75 neurotrophin receptor remains preliminary. Heterogeneity in sampling timing, normalization, and cohort composition, together with single-center designs and risk of bias, precludes clinical implementation. Standardized pre-analytical protocols and multicenter validation of multiplexed panels are required before urinary testing can support clinical decision-making.

Related

  1. Gut Microbiome Disruption in Traumatic Brain Injury and Therapeutic Potential of Probiotics: A Systematic Review and Meta-Analysis.
    Zeeshan A Khan, Zara Chowdhury, Riya Modi +5
    BiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. Gut-microbiota-brain axis as a potential source of susceptibility/risk biomarkers for post-traumatic epilepsy: an opinion review
    Andrey M. Mazarati, Mulugeta Million, Muriel Larauche +1
    Experimental neurologyPeer-reviewedLicence not statedFull text1 citedMolecular biology & gene regulationPMC
  3. Circulating MicroRNAs as Molecular Biomarkers of Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Candidate-Centered Evidence Map
    Antônio da Silva Menezes, Arthur de Sousa Silva, Alcir Júnior de Paula Nunes Meneses +2
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  4. To Recover or Not to Recover: A Urinary Proteomic Perspective on Severe Acute Kidney Injury
    A. Q. Figueiredo, I. F. Domingos, S. Coelho +11
    bioRxivPreprintAll rights reservedFull textGeneral biochemistrybioRxiv
  5. Discovery of metabolite biomarkers for cerebral ischemia-reperfusion injury based on metabolomics: neurotoxic mechanism and functional validation of a flavopiridol -related metabolite
    Zhi-guang Song, Yu-chen Liu, Zhen-lin Zhong +12
    Frontiers in molecular biosciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{ding2026urinary,
  title = {{Urinary Biomarkers in Traumatic Brain Injury: A Systematic Review}},
  author = {Xinyu Ding and Yu Deng and Guoyi Gao and Liang Wu},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210224},
  url = {https://www.mdpi.com/1422-0067/27/22/10224},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Urinary Biomarkers in Traumatic Brain Injury: A Systematic Review
AU  - Xinyu Ding
AU  - Yu Deng
AU  - Guoyi Gao
AU  - Liang Wu
PY  - 2026
DA  - 2026/11/14
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210224
UR  - https://www.mdpi.com/1422-0067/27/22/10224
AB  - An accurate diagnosis and longitudinal monitoring of traumatic brain injury (TBI) require non-invasive, objective metrics. This systematic review evaluates the clinical utility of urinary biomarkers across the TBI spectrum. Following the PRISMA 2020 guidelines, we searched PubMed and Web of Science and identified 25 empirical human studies after applying the inclusion and exclusion criteria. The included studies fell into four categories as follows: central nervous system structural and glial proteins, metabolomic and volatile signatures, peptidomic and systemic indicators, and emerging targets. Urinary S100B was associated with injury severity and, in one severe-TBI cohort, with one-month mortality at an area under the curve of 0.778, yet its discriminative value in mild TBI was limited by delayed renal excretion and pre-analytical confounders. Metabolomic and peptidomic panels showed promising classification accuracy in small cohorts, and early urinary liver-type fatty acid-binding protein and a depressed urine-to-serum osmolality ratio signaled secondary renal and neuroendocrine complications. Evidence for microRNAs, glycans, and the p75 neurotrophin receptor remains preliminary. Heterogeneity in sampling timing, normalization, and cohort composition, together with single-center designs and risk of bias, precludes clinical implementation. Standardized pre-analytical protocols and multicenter validation of multiplexed panels are required before urinary testing can support clinical decision-making.
SN  - 1422-0067
ER  -